Boelaert J, Meyrier A, Sraer J D, Morel-Maroger L, Kourilsky O, Dard S, El Nahas M, Van Eeghem P, Daneels R
Nephrologie. 1981;2(3):92-5.
We report on 4 cases of reversible acute renal failure (ARF), appearing within the first days after institution of a sulfinpyrazone treatment (600 mg p. day) early after a myocardial infarction. Urinary data were consistent with an acute tubular necrosis. A renal biopsy, performed in 3 patients, revealed only very discrete tubular and interstitial lesions, not helpful in the understanding of the ARF. Three pathogenetic mechanisms could be evoked. Data in favour of an acute tubular precipitation of uric acid or an immunologically induced acute interstitial nephritis are lacking. More probably this ARF is due to an inhibitory effect of sulfinpyrazone on the renal prostaglandin synthesis. Early after a myocardial infarction, renal prostaglandins could play an important protective role in maintaining the renal circulation. Renal function should be monitored closely when sulfinpyrazone is prescribed, especially early after a myocardial infarction.
我们报告了4例可逆性急性肾衰竭(ARF)病例,这些病例在心肌梗死后早期开始使用苯磺唑酮治疗(每日600毫克)后的头几天内出现。尿液检查数据与急性肾小管坏死一致。对3例患者进行了肾活检,结果仅显示非常轻微的肾小管和间质病变,对理解急性肾衰竭并无帮助。可以提出三种发病机制。缺乏支持尿酸急性肾小管沉淀或免疫诱导的急性间质性肾炎的数据。这种急性肾衰竭更可能是由于苯磺唑酮对肾前列腺素合成的抑制作用。在心肌梗死后早期,肾前列腺素可能在维持肾循环中起重要的保护作用。当开具苯磺唑酮处方时,尤其是在心肌梗死后早期,应密切监测肾功能。